Issues related to health data privacy and security, patient access to data, real-time benefit tools, and clinical decision support software; Issues related to health data interoperability, standards, information blocking, and the access, exchange, and use of health data; access to and coverage of telehealth services, including mental and behavioral health services, broadband access and infrastructure development; Issues related to the use of artificial intelligence in health care.
Duration: October 1, 2019
to
present
General Issues: Health Issues
Spending: about $360,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2019: U.S. Senate, House of Representatives, Health & Human Services - Dept of (HHS)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist
Covered positions?
Joel White Former Staff Director, House Ways & Means Health Subcommittee
Former Staff Director, House Ways & Means Health Subcommittee; L.A. for Rep. Jim Greenwood; L.A. for Rep. Chris Shays
Jennifer Steger Scheduler/Legislative Assistant, Rep Jean Schmidt; Executive Assistant, Rep Jim Gerlach
Scheduler/Legislative Assistant, Rep. Jean Schmidt; Executive Assistant/Legislative Assistant, Rep. Jim Gerlach
Emily Shetty Former LD, Rep Edolphus "Ed" Towns
Former LD, Rep. Edolphus "Ed" Towns
Brett Meeks Former Deputy Health Policy Director for the Senate Committee on Health, Education, Labor and Pensions
Catherine Pugh n/a
Allison Wils n/a
Amanda Krzepicki n/a
Peter Dudziak n/a
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
1st Quarter, 2024
In Q1, Horizon Government Affairs lobbied for Health Innovation Alliance , earning $20,000. The report was filed on April 14.
Original Filing: 301549237.xml
Lobbying Issues
Issues related to health data privacy and security, patient access to data, real-time benefit tools, and clinical decision support software; Issues related to health data interoperability, standards, information blocking, and the access, exchange, and use of health data; access to and coverage of telehealth services, including mental and behavioral health services, broadband access and infrastructure development; Issues related to the use of artificial intelligence in health care.
Agencies Lobbied
U.S. Senate
4th Quarter, 2023
In Q4, Horizon Government Affairs lobbied for Health Innovation Alliance , earning $20,000. The report was filed on Jan. 17.
Original Filing: 301526561.xml
Lobbying Issues
Issues related to health data privacy and security, patient access to data, real-time benefit tools, and clinical decision support software; Issues related to health data interoperability, standards, information blocking, and the access, exchange, and use of health data; access to and coverage of telehealth services, including mental and behavioral health services, broadband access and infrastructure development; CDC reform and public health data modernization; reauthorization of the Pandemic and All Hazards Preparedness Act; Issues related to the use of artificial intelligence in health care.
Agencies Lobbied
U.S. Senate
3rd Quarter, 2023
In Q3, Horizon Government Affairs lobbied for Health Innovation Alliance , earning $20,000. The report was filed on Oct. 17, 2023.
Original Filing: 301503215.xml
Lobbying Issues
Issues related to health data privacy and security, patient access to data, real-time benefit tools, and clinical decision support software; Issues related to health data interoperability, standards, information blocking, and the access, exchange, and use of health data; access to and coverage of telehealth services, including mental and behavioral health services, broadband access and infrastructure development; CDC reform and public health data modernization; reauthorization of the Pandemic and All Hazards Preparedness Act.
Agencies Lobbied
U.S. Senate
2nd Quarter, 2023
In Q2, Horizon Government Affairs lobbied for Health Innovation Alliance , earning $20,000. The report was filed on July 17, 2023.
Original Filing: 301478405.xml
Lobbying Issues
Issues related to health data privacy and security, patient access to data, real-time benefit tools, and clinical decision support software; Issues related to health data interoperability, standards, information blocking, and the access, exchange, and use of health data; access to and coverage of telehealth services, including mental and behavioral health services, broadband access and infrastructure development; CDC reform and public health data modernization; reauthorization of the Pandemic and All Hazards Preparedness Act.
Agencies Lobbied
U.S. Senate
1st Quarter, 2023
In Q1, Horizon Government Affairs lobbied for Health Innovation Alliance , earning $20,000. The report was filed on April 16, 2023.
Original Filing: 301452233.xml
Lobbying Issues
Issues related to health data privacy and security, patient access to data, real-time benefit tools, and clinical decision support software; Issues related to health data interoperability, standards, information blocking, and the access, exchange, and use of health data; access to and coverage of telehealth services, including mental and behavioral health services, broadband access and infrastructure development; CDC reform and public health data modernization; reauthorization of the Pandemic and All Hazards Preparedness Act.
Agencies Lobbied
U.S. Senate
4th Quarter, 2022
In Q4, Horizon Government Affairs lobbied for Health Innovation Alliance , earning $30,000. The report was filed on Jan. 19, 2023.
Original Filing: 301435388.xml
Lobbying Issues
21st Century Cures Act (PL 114-255) implementation an oversight; SUPPORT for Patients and Communities Act (PL 115-271) implementation and oversight; issues related to health data privacy, unique patient identifier and patient matching, patient access to data, pharmacy real-time benefit transactions; standards to increase interoperability; Medicare coverage of telehealth services, S 368, the Telehealth Modernization Act; the COVID-19 pandemic response including CDC data infrastructure modernization, telemental and telebahavioral health, broadband access and infrastructure development, Telehealth Expansion Act, H.R. 5981; Telehealth Extension Act, H.R. 6202; S. 3799, the PREVENT Pandemics Act; H.R. 8152 - the American Data Privacy and Protection Act
Agencies Lobbied
U.S. Senate
3rd Quarter, 2022
In Q3, Horizon Government Affairs lobbied for Health Innovation Alliance , earning $20,000. The report was filed on Oct. 16, 2022.
Original Filing: 301404895.xml
Lobbying Issues
21st Century Cures Act (PL 114-255) implementation an oversight; SUPPORT for Patients and Communities Act (PL 115-271) implementation and oversight; issues related to health data privacy, unique patient identifier and patient matching, patient access to data, pharmacy real-time benefit transactions; standards to increase interoperability; Medicare coverage of telehealth services, S 368, the Telehealth Modernization Act; the COVID-19 pandemic response including CDC data infrastructure modernization, telemental and telebahavioral health, broadband access and infrastructure development, Telehealth Expansion Act, H.R. 5981; Telehealth Extension Act, H.R. 6202; S. 3799, the PREVENT Pandemics Act; H.R. 8152 - the American Data Privacy and Protection Act
Agencies Lobbied
U.S. Senate
2nd Quarter, 2022
In Q2, Horizon Government Affairs lobbied for Health Innovation Alliance , earning $20,000. The report was filed on July 19, 2022.
Original Filing: 301387483.xml
Lobbying Issues
21st Century Cures Act (PL 114-255) implementation an oversight; SUPPORT for Patients and Communities Act (PL 115-271) implementation and oversight; issues related to health data privacy, unique patient identifier and patient matching, patient access to data, pharmacy real-time benefit transactions; standards to increase interoperability; Medicare coverage of telehealth services, S 368, the Telehealth Modernization Act; the COVID-19 pandemic response including CDC data infrastructure modernization, telemental and telebahavioral health, broadband access and infrastructure development, Telehealth Expansion Act, H.R. 5981; Telehealth Extension Act, H.R. 6202; S. 3799, the PREVENT Pandemics Act; H.R. 8152 - the American Data Privacy and Protection Act
Agencies Lobbied
U.S. Senate
1st Quarter, 2022
In Q1, Horizon Government Affairs lobbied for Health Innovation Alliance , earning $20,000. The report was filed on April 19, 2022.
Original Filing: 301363524.xml
Lobbying Issues
21st Century Cures Act (PL 114-255) implementation an oversight; SUPPORT for Patients and Communities Act (PL 115-271) implementation and oversight; issues related to health data privacy, unique patient identifier and patient matching, patient access to data, pharmacy real-time benefit transactions; standards to increase interoperability; Medicare coverage of telehealth services, S 368, the Telehealth Modernization Act; the COVID-19 pandemic response including CDC data infrastructure modernization, telemental and telebahavioral health, broadband access and infrastructure development, HR 1317, the American Rescue Plan Act; Telehealth Expansion Act, H.R. 5981; Telehealth Extension Act, H.R. 6202; S. 3799, the PREVENT Pandemics Act
Agencies Lobbied
U.S. Senate
4th Quarter, 2021
In Q4, Horizon Government Affairs lobbied for Health Innovation Alliance , earning $10,000. The report was filed on Jan. 17, 2022.
Original Filing: 301324336.xml
Lobbying Issues
21st Century Cures Act (PL 114-255) implementation an oversight; SUPPORT for Patients and Communities Act (PL 115-271) implementation and oversight; issues related to health data privacy, unique patient identifier and patient matching, patient access to data, pharmacy real-time benefit transactions; standards to increase interoperability; Medicare coverage of telehealth services, S 368, the Telehealth Modernization Act; the COVID-19 pandemic response including CDC data infrastructure modernization, vaccine distribution and verification, HR 550, the Immunization Infrastructure Modernization Act, HR 318, the Safe Testing at Residence Telehealth Act, telemental and telebahavioral health, broadband access and infrastructure development, HR 1317, the American Rescue Plan Act; Telehealth Expansion Act, H.R. 5981; Telehealth Extension Act, H.R. 6202
Agencies Lobbied
U.S. Senate
3rd Quarter, 2021
In Q3, Horizon Government Affairs lobbied for Health Innovation Alliance , earning $30,000. The report was filed on Oct. 19, 2021.
Original Filing: 301305193.xml
Lobbying Issues
21st Century Cures Act (PL 114-255) implementation an oversight; SUPPORT for Patients and Communities Act (PL 115-271) implementation and oversight; issues related to health data privacy, unique patient identifier and patient matching, patient access to data, pharmacy real-time benefit transactions; Medicare coverage of telehealth services, S 368, the Telehealth Modernization Act; the COVID-19 pandemic response including CDC data infrastructure modernization, vaccine distribution and verification, HR 550, the Immunization Infrastructure Modernization Act, HR 318, the Safe Testing at Residence Telehealth Act, telemental and telebahavioral health, broadband access and infrastructure development, HR 1317, the American Rescue Plan Act.
Agencies Lobbied
U.S. Senate
2nd Quarter, 2021
In Q2, Horizon Government Affairs lobbied for Health Innovation Alliance , earning $30,000. The report was filed on July 14, 2021.
Original Filing: 301276172.xml
Lobbying Issues
21st Century Cures Act (PL 114-255) implementation an oversight; SUPPORT for Patients and Communities Act (PL 115-271) implementation and oversight; issues related to health data privacy, unique patient identifier and patient matching, patient access to data, pharmacy real-time benefit transactions; Medicare coverage of telehealth services, S 368, the Telehealth Modernization Act; the COVID-19 pandemic response including CDC data infrastructure modernization, vaccine distribution and verification, HR 550, the Immunization Infrastructure Modernization Act, HR 318, the Safe Testing at Residence Telehealth Act, telemental and telebahavioral health, broadband access and infrastructure development, HR 1317, the American Rescue Plan Act.
Agencies Lobbied
U.S. Senate
1st Quarter, 2021
In Q1, Horizon Government Affairs lobbied for Health Innovation Alliance , earning $20,000. The report was filed on April 14, 2021.
Original Filing: 301252915.xml
Lobbying Issues
21st Century Cures Act (PL 114-255) implementation an oversight; SUPPORT for Patients and Communities Act (PL 115-271) implementation and oversight; issues related to health data privacy, unique patient identifier and patient matching, patient access to data, pharmacy real-time benefit transactions; Medicare coverage of telehealth services, S 368, the Telehealth Modernization Act; the COVID-19 pandemic response including CDC data infrastructure modernization, vaccine distribution and verification, HR 318, the Safe Testing at Residence Telehealth Act, telemental and telebahavioral health, modernization of HCAHPS, broadband access and infrastructure development, HR 1317, the American Rescue Plan Act.
Agencies Lobbied
U.S. Senate
4th Quarter, 2020
In Q4, Horizon Government Affairs lobbied for Health Innovation Alliance , earning $10,000. The report was filed on Jan. 8, 2021.
Original Filing: 301229354.xml
Lobbying Issues
21st Century Cures Act (P.L. 114-255) implementation and oversight; SUPPORT for Patients and Communities Act (P.L. 115-271) implementation and oversight; Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2019 (S. 2741/HR 4932); Issues related to health data privacy; Labor, Health and Human Services, Education, Defense, State, Foreign Operations, and Energy and Water Development Appropriations Act, 2020 (HR 2740) - issues related to unique patient identifier and patient matching; the Analyzing and Leveraging Existing Rx Transactions Act of 2019 (H.R. 1845); the Protecting Jessica Grubbs Legacy Act (S. 3374); The Mental Health Telemedicine Expansion Act (HR 1301); the Shop Rx Act (HR 3408); The Real-Time Beneficiary Drug Cost Bill (HR 3415); issues related to patient access to data; issues related to pharmacy real-time benefit transactions; issues related to Medicare coverage of telehealth services; issues relating to increased access to treatment for opioid misuse and abuse; issues relating to increased use of technology to combat opioid epidemic; Prescription Drug Pricing Reduction Act (S. 2543); Public Disclosure of Drug Discounts and Real-Time Beneficiary Drug Cost Act (H.R. 2115); issues related to the COVID-19 pandemic response; Issues around CDC and data infrastructure modernization: H.R. 748, the Coronavirus Aid, Relief and Economic Security (CARES) Act, H.R. 6800, Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act. Issues related to telemental and telebehavioral health; issues related to remote patient monitoring; the Increasing Rural Health Access During the COVID-19 Public Health Emergency Act of 2020 (H.R. 7190/S. 3951); issues related to ERISA and telehealth; issues related to broadband and infrastructure development; the Protecting Access to Post-Covid-19 Telehealth Act; issues related to modernization of HCAHPS; add HR 133, the Consolidated Appropriations Act 2021.
Agencies Lobbied
U.S. Senate
3rd Quarter, 2020
In Q3, Horizon Government Affairs lobbied for Health Innovation Alliance , earning $10,000. The report was filed on Oct. 19, 2020.
Original Filing: 301216539.xml
Lobbying Issues
21st Century Cures Act (P.L. 114-255) implementation and oversight; SUPPORT for Patients and Communities Act (P.L. 115-271) implementation and oversight; Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2019 (S. 2741/HR 4932); Issues related to health data privacy; Labor, Health and Human Services, Education, Defense, State, Foreign Operations, and Energy and Water Development Appropriations Act, 2020 (HR 2740) - issues related to unique patient identifier and patient matching; the Analyzing and Leveraging Existing Rx Transactions Act of 2019 (H.R. 1845); the Protecting Jessica Grubbs Legacy Act (S. 3374); The Mental Health Telemedicine Expansion Act (HR 1301); the Shop Rx Act (HR 3408); The Real-Time Beneficiary Drug Cost Bill (HR 3415); issues related to patient access to data; issues related to pharmacy real-time benefit transactions; issues related to Medicare coverage of telehealth services; issues relating to increased access to treatment for opioid misuse and abuse; issues relating to increased use of technology to combat opioid epidemic; Prescription Drug Pricing Reduction Act (S. 2543); Public Disclosure of Drug Discounts and Real-Time Beneficiary Drug Cost Act (H.R. 2115); issues related to the COVID-19 pandemic response; Issues around CDC and data infrastructure modernization: H.R. 748, the Coronavirus Aid, Relief and Economic Security (CARES) Act, H.R. 6800, Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act. Issues related to telemental and telebehavioral health; issues related to remote patient monitoring; the Increasing Rural Health Access During the COVID-19 Public Health Emergency Act of 2020 (H.R. 7190/S. 3951); issues related to ERISA and telehealth; issues related to broadband and infrastructure development; the Protecting Access to Post-Covid-19 Telehealth Act; issues related to modernization of HCAHPS.
Agencies Lobbied
U.S. Senate
2nd Quarter, 2020
In Q2, Horizon Government Affairs lobbied for Health Innovation Alliance , earning $20,000. The report was filed on July 17, 2020.
Original Filing: 301190837.xml
Lobbying Issues
21st Century Cures Act (P.L. 114-255) implementation and oversight; SUPPORT for Patients and Communities Act (P.L. 115-271) implementation and oversight; Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2019 (S. 2741/HR 4932); Issues related to health data privacy; Labor, Health and Human Services, Education, Defense, State, Foreign Operations, and Energy and Water Development Appropriations Act, 2020 (HR 2740) - issues related to unique patient identifier and patient matching; the Analyzing and Leveraging Existing Rx Transactions Act of 2019 (H.R. 1845); The Overdose Prevention and Patient Safety Act (HR 2062); the Protecting Jessica Grubbs Legacy Act (S. 1012 and S. 3374); The Mental Health Telemedicine Expansion Act (HR 1301); the Shop Rx Act (HR 3408); The Real-Time Beneficiary Drug Cost Bill (HR 3415); issues related to patient access to data; issues related to pharmacy real-time benefit transactions; issues related to Medicare coverage of telehealth services; issues relating to increased access to treatment for opioid misuse and abuse; issues relating to increased use of technology to combat opioid epidemic; Prescription Drug Pricing Reduction Act (S. 2543); Public Disclosure of Drug Discounts and Real-Time Beneficiary Drug Cost Act (H.R. 2115); issues related to the COVID-19 pandemic response; Issues around CDC and data infrastructure modernization: H.R. 748, the Coronavirus Aid, Relief and Economic Security (CARES) Act, H.R. 6800, Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act. Issues related to telemental and telebehavioral health; issues related to remote patient monitoring; the Increasing Rural Health Access During the COVID-19 Public Health Emergency Act of 2020 (H.R. 7190/S. 3951); issues related to ERISA and telehealth; issues related to broadband and infrastructure development; the Protecting Access to Post-Covid-19 Telehealth Act.
Agencies Lobbied
U.S. Senate
1st Quarter, 2020
In Q1, Horizon Government Affairs lobbied for Health Innovation Alliance , earning $20,000. The report was filed on April 15, 2020.
Original Filing: 301167610.xml
Lobbying Issues
21st Century Cures Act (P.L. 114-255) implementation and oversight; SUPPORT for Patients and Communities Act (P.L. 115-271) implementation and oversight; Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2019 (S. 2741/HR 4932); Issues related to health data privacy; Labor, Health and Human Services, Education, Defense, State, Foreign Operations, and Energy and Water Development Appropriations Act, 2020 (HR 2740) - issues related to unique patient identifier and patient matching; the Analyzing and Leveraging Existing Rx Transactions Act of 2019 (H.R. 1845); The Overdose Prevention and Patient Safety Act (HR 2062); the Protecting Jessica Grubbs Legacy Act (S. 1012 and S. 3374); The Mental Health Telemedicine Expansion Act (HR 1301); the Shop Rx Act (HR 3408); The Real-Time Beneficiary Drug Cost Bill (HR 3415); issues related to patient access to data; issues related to pharmacy real-time benefit transactions; issues related to Medicare coverage of telehealth services; issues relating to increased access to treatment for opioid misuse and abuse; issues relating to increased use of technology to combat opioid epidemic; Prescription Drug Pricing Reduction Act (S. 2543); Public Disclosure of Drug Discounts and Real-Time Beneficiary Drug Cost Act (H.R. 2115); issues related to the COVID-19 pandemic response
Agencies Lobbied
U.S. Senate
4th Quarter, 2019
In Q4, Horizon Government Affairs lobbied for Health Innovation Alliance , earning $20,000. The report was filed on Jan. 11, 2020.
Original Filing: 301104456.xml
Lobbying Issues
21st Century Cures Act (P.L. 114-255) implementation and oversight; SUPPORT for Patients and Communities Act (P.L. 115-271) implementation and oversight; the Reducing Unnecessary Senior Hospitalization Act (HR 6502, 115th); the Analyzing and Leveraging Existing Rx Transactions Act of 2019 (H.R. 1845); The Overdose Prevention and Patient Safety Act (HR 2062); the Protecting Jessica Grubbs Legacy Act (S. 1012); The Mental Health Telemedicine Expansion Act (HR 1301); the Shop Rx Act (HR 3408); The Real-Time Beneficiary Drug Cost Bill (HR 3415); issues related to patient access to data; issues related to pharmacy real-time benefit transactions; issues related to Medicare coverage of telehealth services; issues relating to increased access to treatment for opioid misuse and abuse; issues relating to increased use of technology to combat opioid epidemic; Prescription Drug Pricing Reduction Act (S. 2543); Public Disclosure of Drug Discounts and Real-Time Beneficiary Drug Cost Act (H.R. 2115)
Agencies Lobbied
U.S. Senate
4th Quarter, 2019
Horizon Government Affairs amended a lobbying report for representation of Health Innovation Alliance in Q42019 on Jan. 11, 2020.
Original Filing: 301104457.xml
Lobbying Issues
21st Century Cures Act (P.L. 114-255) implementation and oversight; SUPPORT for Patients and Communities Act (P.L. 115-271) implementation and oversight; Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2019 (S. 2741/HR 4932); Issues related to health data privacy; Labor, Health and Human Services, Education, Defense, State, Foreign Operations, and Energy and Water Development Appropriations Act, 2020 (HR 2740) - issues related to unique patient identifier and patient matching; the Analyzing and Leveraging Existing Rx Transactions Act of 2019 (H.R. 1845); The Overdose Prevention and Patient Safety Act (HR 2062); the Protecting Jessica Grubbs Legacy Act (S. 1012); The Mental Health Telemedicine Expansion Act (HR 1301); the Shop Rx Act (HR 3408); The Real-Time Beneficiary Drug Cost Bill (HR 3415); issues related to patient access to data; issues related to pharmacy real-time benefit transactions; issues related to Medicare coverage of telehealth services; issues relating to increased access to treatment for opioid misuse and abuse; issues relating to increased use of technology to combat opioid epidemic; Prescription Drug Pricing Reduction Act (S. 2543); Public Disclosure of Drug Discounts and Real-Time Beneficiary Drug Cost Act (H.R. 2115)
Agencies Lobbied
U.S. Senate
4th Quarter, 2019
Horizon Government Affairs filed a lobbying registration on Oct. 17, 2019 to represent Health Innovation Alliance, effective Oct. 1, 2019.
Original Filing: 301068565.xml
Issue(s) they said they’d lobby about: Removing federal barriers to the use of technology in health care in order to: create value for patients by transforming care, improving connectivity, enhancing patient access, and streamlining the regulatory process. .
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate
Searching...